Related Experiment Video
Updated: Feb 10, 2026
08:10
A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
14.2K
BCG therapy in NMIBC: How much and for how long?.
Annelisse Ashton1, Venkata Ramana Murthy Kusuma1, Jeremy Crew2
1Departamento de Urología. Royal Surrey County Hospital. Egerton Road. Guildford. Surrey. UK.
Archivos Espanoles De Urologia
|May 11, 2018
Summary
Optimizing Bacille Calmette-Guerin (BCG) treatment for high-risk non-muscle-invasive bladder cancer (NMIBC) requires further research. Studies are needed to determine the ideal BCG dose and maintenance duration to balance effectiveness and side effects.
Area of Science:
- Oncology
- Urology
- Immunotherapy
Background:
- Bacille Calmette-Guerin (BCG) is the standard treatment for high-risk non-muscle-invasive bladder cancer (NMIBC) since 1976.
- Optimal BCG dosage and maintenance protocols remain undetermined despite extensive use.
- Current BCG supply shortages highlight the need for treatment optimization.
Purpose of the Study:
- To review the current evidence on BCG treatment for NMIBC.
- To identify knowledge gaps regarding optimal BCG dose and maintenance duration.
- To emphasize the need for high-quality randomized trials to refine BCG therapy.
Main Methods:
- Review of existing literature on BCG treatment in NMIBC.
- Analysis of comparative effectiveness data for different BCG doses.
- Evaluation of evidence supporting BCG maintenance therapy duration.
Main Results:
- While a 6-week induction course is standard, comparative data on one-third versus full BCG dose is inconclusive.
- Evidence supports BCG maintenance, but optimal regimens are unknown.
- Minimum effective maintenance appears to be 12 months; no benefit beyond 36 months.
Conclusions:
- Further high-quality randomized trials are essential to establish optimal BCG dosage and treatment duration for NMIBC.
- Optimizing BCG therapy is critical, especially given global supply challenges.
- Refining treatment protocols can improve efficacy while minimizing side effects in NMIBC patients.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
11.1K
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
9.8K
Related Concept Videos
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:26Group Therapy
459
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
459
01:22Behavior Therapy
732
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
732
01:28Drug Therapy
304
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
304
01:25Cognitive Therapy
1.1K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.1K
01:30Electroconvulsive Therapy
1.2K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.2K